HIV Drug Lenacapavir Disrupts Late Assembly to Form Giant Noninfectious Particles
Researchers have discovered that the HIV drug lenacapavir binds precursor Gag proteins during late viral assembly, generating oversized, non-infectious particles.
Researchers have discovered that the HIV drug lenacapavir binds precursor Gag proteins during late viral assembly, generating oversized, non-infectious particles.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.